Influenza Vaccine Effectiveness: What’s the Problems with H3N2?


Observational studies of influenza vaccine effectiveness over the past decade have yielded new insights into differences by subtype, product type, and age group. One consistent finding is that effectiveness against H3N2 is low compared to H1N1pdm09 and type B. Characteristics of the virus, vaccine and host immune environment likely contribute to this problem. Understanding these effects will be critical for efforts to develop more effective seasonal vaccines, and ultimately a universal vaccine.

Presented by: Edward Belongia, MD, Director, Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute

Monday, November 12th, 2018

12:00-1:00 pm

1335 Health Sciences Learning Center


Attachment 1
Attachment 2

This post was authored by Rosalind Bendix-Lewis on 11/09/2018.